Harris Alex H S, Gupta Shalini, Bowe Thomas, Ellerbe Laura S, Phelps Tyler E, Rubinsky Anna D, Finney John W, Asch Steven M, Humphreys Keith, Trafton Jodie
Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, CA, USA.
Addict Sci Clin Pract. 2015 Oct 31;10:22. doi: 10.1186/s13722-015-0042-5.
In order to monitor and ultimately improve the quality of addiction treatment, professional societies, health care systems, and addiction treatment programs must establish clinical practice standards and then operationalize these standards into reliable, valid, and feasible quality measures. Before being implemented, quality measures should undergo tests of validity, including predictive validity. Predictive validity refers to the association between process-of-care quality measures and subsequent patient outcomes. This study evaluated the predictive validity of two process quality measures of residential substance use disorder (SUD) treatment.
Washington Circle (WC) Continuity of Care quality measure is the proportion of patients having an outpatient SUD treatment encounter within 14 days after discharge from residential SUD treatment. The Early Discharge measure is the proportion of patients admitted to residential SUD treatment who discharged within 1 week of admission. The predictive validity of these process measures was evaluated in US Veterans Health Administration patients for whom utilization-based outcome and 2-year mortality data were available. Propensity score-weighted, mixed effects regression adjusted for pre-index imbalances between patients who did and did not meet the measures' criteria and clustering of patients within facilities.
For the WC Continuity of Care measure, 76 % of 10,064 patients had a follow-up visit within 14 days of discharge. In propensity score-weighted models, patients who had a follow-up visit had a lower 2-year mortality rate [odds ratio (OR) = 0.77, p = 0.008], but no difference in subsequent detoxification episodes relative to patients without a follow-up visit. For the Early Discharge measure, 9.6 % of 10,176 discharged early and had significantly higher 2-year mortality (OR = 1.49, p < 0.001) and more subsequent detoxification episodes.
These two measures of residential SUD treatment quality have strong associations with 2-year mortality and the Early Discharge measure is also associated with more subsequent detoxification episodes. These results provide initial support for the predictive validity of residential SUD treatment quality measures and represent the first time that any SUD quality measure has been shown to predict subsequent mortality.
为了监测并最终提高成瘾治疗的质量,专业协会、医疗保健系统和成瘾治疗项目必须制定临床实践标准,然后将这些标准转化为可靠、有效且可行的质量指标。在实施之前,质量指标应进行效度测试,包括预测效度。预测效度是指护理过程质量指标与后续患者结局之间的关联。本研究评估了住院物质使用障碍(SUD)治疗的两项过程质量指标的预测效度。
华盛顿圈(WC)连续护理质量指标是指在住院SUD治疗出院后14天内接受门诊SUD治疗的患者比例。早期出院指标是指入住住院SUD治疗的患者在入院后1周内出院的比例。在美国退伍军人健康管理局的患者中评估了这些过程指标的预测效度,这些患者可获得基于利用情况的结局和2年死亡率数据。倾向得分加权混合效应回归对达到和未达到指标标准的患者之间的指数前失衡以及设施内患者的聚类进行了调整。
对于WC连续护理指标,10064名患者中有76%在出院后14天内进行了随访。在倾向得分加权模型中,进行随访的患者2年死亡率较低[比值比(OR)=0.77,p=0.008],但与未进行随访的患者相比,后续戒毒发作次数没有差异。对于早期出院指标,10176名患者中有9.6%提前出院,2年死亡率显著更高(OR=1.49,p<0.001),后续戒毒发作次数更多。
这两项住院SUD治疗质量指标与2年死亡率密切相关,早期出院指标也与更多后续戒毒发作次数相关。这些结果为住院SUD治疗质量指标的预测效度提供了初步支持,并且首次表明任何SUD质量指标都能预测后续死亡率。